254 related articles for article (PubMed ID: 27634429)
1. Identification of novel antigens contributing to autoimmunity in cardiovascular diseases.
Müller AM; Bockstahler M; Hristov G; Weiß C; Fischer A; Korkmaz-Icöz S; Giannitsis E; Poller W; Schultheiss HP; Katus HA; Kaya Z
Clin Immunol; 2016 Dec; 173():64-75. PubMed ID: 27634429
[TBL] [Abstract][Full Text] [Related]
2. Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. Therapeutic implications for the human disease.
Martín R; Cordova C; San Román JA; Gutierrez B; Cachofeiro V; Nieto ML
J Mol Cell Cardiol; 2014 Jul; 72():250-62. PubMed ID: 24732212
[TBL] [Abstract][Full Text] [Related]
3. Myosin-primed tolerogenic dendritic cells ameliorate experimental autoimmune myocarditis.
Lee JH; Kim TH; Park HE; Lee EG; Jung NC; Song JY; Seo HG; Seung KB; Chang K; Lim DS
Cardiovasc Res; 2014 Feb; 101(2):203-10. PubMed ID: 24189626
[TBL] [Abstract][Full Text] [Related]
4. [Autoantibodies against cardiac myosin in patients with myocarditis and dilated cardiomyopathy].
Lauer B; Padberg K; Schultheiss HP; Strauer BE
Z Kardiol; 1995 Apr; 84(4):301-10. PubMed ID: 7785303
[TBL] [Abstract][Full Text] [Related]
5. Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats.
Okura Y; Takeda K; Honda S; Hanawa H; Watanabe H; Kodama M; Izumi T; Aizawa Y; Seki S; Abo T
Circ Res; 1998 Jun; 82(10):1035-42. PubMed ID: 9622156
[TBL] [Abstract][Full Text] [Related]
6. SR-Ca2+ ATPase as an autoimmunogen in experimental myocarditis.
Khaw BA; Narula J; Sharaf AR; Nicol PD; Southern JF; Carles M
Eur Heart J; 1995 Dec; 16 Suppl O():92-6. PubMed ID: 8682113
[TBL] [Abstract][Full Text] [Related]
7. Cooperation of Th1 and Th17 cells determines transition from autoimmune myocarditis to dilated cardiomyopathy.
Nindl V; Maier R; Ratering D; De Giuli R; Züst R; Thiel V; Scandella E; Di Padova F; Kopf M; Rudin M; Rülicke T; Ludewig B
Eur J Immunol; 2012 Sep; 42(9):2311-21. PubMed ID: 22730043
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of myocarditis and dilated cardiomyopathy.
Cihakova D; Rose NR
Adv Immunol; 2008; 99():95-114. PubMed ID: 19117533
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S
Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
[TBL] [Abstract][Full Text] [Related]
10. Anti-heart autoantibodies in familial dilated cardiomyopathy.
Caforio AL; Vinci A; Iliceto S
Autoimmunity; 2008 Sep; 41(6):462-9. PubMed ID: 18781472
[TBL] [Abstract][Full Text] [Related]
11. Myocarditis Elicits Dendritic Cell and Monocyte Infiltration in the Heart and Self-Antigen Presentation by Conventional Type 2 Dendritic Cells.
Van der Borght K; Scott CL; Martens L; Sichien D; Van Isterdael G; Nindl V; Saeys Y; Boon L; Ludewig B; Gillebert TC; Lambrecht BN
Front Immunol; 2018; 9():2714. PubMed ID: 30524444
[TBL] [Abstract][Full Text] [Related]
12. Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy.
Caforio AL; Mahon NJ; Mckenna WJ
Autoimmunity; 2001; 34(3):199-204. PubMed ID: 11908778
[TBL] [Abstract][Full Text] [Related]
13. Autoimmunity in myocarditis and dilated cardiomyopathy: cardiac autoantibody frequency and clinical correlates in a patient series from Italy.
Caforio AL; Bauce B; Boffa GM; De Cian F; Angelini A; Melacini P; Razzolini R; Fasoli G; Chioin R; Schiaffino S; Thiene G; Dalla Volta S
G Ital Cardiol; 1997 Feb; 27(2):106-12. PubMed ID: 9199945
[TBL] [Abstract][Full Text] [Related]
14. [Immunoserologic and immunohistologic studies of myocarditis and pericarditis].
Maisch B; Schönian U; Herzum M; Hufnagel G
Internist (Berl); 1995 May; 36(5):448-57. PubMed ID: 7601618
[No Abstract] [Full Text] [Related]
15. Clinical significance and pathogenic role of anti-cardiac myosin autoantibody in dilated cardiomyopathy.
Wang Z; Liao Y; Dong J; Li S; Wang J; Fu ML
Chin Med J (Engl); 2003 Apr; 116(4):499-502. PubMed ID: 12875710
[TBL] [Abstract][Full Text] [Related]
16. Regulation of inflammation and myocardial fibrosis in experimental autoimmune myocarditis.
Watanabe K; Sukumaran V; Veeraveedu PT; Thandavarayan RA; Gurusamy N; Ma M; Arozal W; Sari FR; Lakshmanan AP; Arumugam S; Soetikno V; Rajavel V; Suzuki K
Inflamm Allergy Drug Targets; 2011 Jun; 10(3):218-25. PubMed ID: 21495969
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of anti-cardiac immunity in dilated cardiomyopathy.
Caforio AL; Mahon NG; McKenna WJ
Ernst Schering Res Found Workshop; 2006; (55):169-93. PubMed ID: 16329663
[TBL] [Abstract][Full Text] [Related]
18. [Idiopathic dilated cardiomyopathy: a persistent viral infection or an organ-specific autoimmune disease? The trial of 2 major pathogenetic hypotheses].
Caforio AL; Bonifacio E; Keeling PJ; Grazzini M; Schiaffino S; Bottazzo GF; McKenna WJ
G Ital Cardiol; 1992 Jan; 22(1):63-72. PubMed ID: 1624070
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory dilated cardiomyopathy (DCMI).
Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
[TBL] [Abstract][Full Text] [Related]
20. Review of microbial infections and the immune response to cardiac antigens.
Penninger JM; Bachmaier K
J Infect Dis; 2000 Jun; 181 Suppl 3():S498-504. PubMed ID: 10839747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]